National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 81533-81534 [2024-23122]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 195 / Tuesday, October 8, 2024 / Notices
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 1, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–23223 Filed 10–7–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Viral Dynamics and
Transmission Study Section, October
24, 2024, 08:00 a.m. to October 25, 2024,
06:00 p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD, 20892 which was
published in the Federal Register on
September 27, 2024, 89 FR 79302.
This meeting is being amended to
change the meeting start and end time
from 8:00 a.m. to 6:00 p.m. to 10:00 a.m.
to 7:00 p.m. The meeting is closed to the
public.
Dated: October 3, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–23221 Filed 10–7–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
VerDate Sep<11>2014
17:23 Oct 07, 2024
Jkt 265001
Mechanisms of Diabetic Cardiovascular
Disease.
Date: November 4, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Manoj Kumar
Valiyaveettil, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA,
National Heart, Lung, and Blood Institute,
National Institutes of Health, 6705 Rockledge
Drive, Room 208–R, Bethesda, MD 20817,
(301) 402–1616, email: manoj.valiyaveettil@
nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Catalyze Product Definition for Small
Molecules and Biologics.
Date: November 6, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Rajiv Kumar, Ph.D.,
Branch Chief, Blood and Vascular Branch,
Office of Scientific Review/DERA, National
Heart, Lung, and Blood Institute, National
Institutes of Health, 6705 Rockledge Drive,
Room 208–W, Bethesda, MD 20892, 301–
827–4612, email: rajiv.kumar@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Support for Conferences and
Scientific Meetings (R13).
Date: November 7, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Cynthia D. Anderson,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes
Health, 6705 Rockledge Drive, Room 207–E,
Bethesda, MD 20892, email:
cynthia.anderson@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Scientific Opportunities For Exploratory
Research.
Date: November 8, 2024.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Sun Saret, Ph.D., Scientific
Review Officer, Office of Scientific Review/
DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208–S, Bethesda, MD
20892, (301) 435–0270, email: sun.saret@
nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Review for Research Education Program to
Enhance Diversity in Health Related
Research.
PO 00000
Frm 00117
Fmt 4703
Sfmt 4703
81533
Date: November 8, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Shelley Sehnert, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Suite 208–T,
Bethesda, MD 20817, (301) 827–7984, email:
ssehnert@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Clinical Trials SEP (UG3, U24).
Date: November 12, 2024.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–J,
Bethesda, MD 20892, (301) 827–7085, email:
zhihong.shan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Mentored Career Development KAwards.
Date: November 14, 2024.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–J,
Bethesda, MD 20892, (301) 827–7085, email:
zhihong.shan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Small Grant Program For NHLBI Award
Recipients (R03).
Date: November 20, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 208–
Z, Bethesda, MD 20892, (301) 827–7987,
email: susan.sunnarborg@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
E:\FR\FM\08OCN1.SGM
08OCN1
81534
Federal Register / Vol. 89, No. 195 / Tuesday, October 8, 2024 / Notices
Dated: October 2, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–23122 Filed 10–7–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Firearm Injury Prevention in Community
Healthcare Settings.
Date: November 7, 2024.
Time: 10:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute of Nursing
Research, 6700B Rockledge Drive, Bethesda,
MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Annie Laurie McRee,
Dr.PH., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 100,
Bethesda, MD 20892, (301) 827–7396,
mcreeal@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Name of Committee: National Center for
Complementary and Integrative Health;
Special Emphasis Panel; Exploratory Clinical
Trials of Mind and Body Interventions (MB).
Date: November 7–8, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Center for
Complementary and Integrative, Democracy
II, 6707 Democracy Blvd., Bethesda, MD
20892.
Meeting Format: Virtual Meeting.
Contact Person: Mei Qin, MD, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Blvd., Suite
401, Bethesda, MD 20892, mei.qin@nih.gov.
Contact Person: MARTA V Hamity, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, MD 20892,
marta.hamity@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: October 2, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: October 2, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–23222 Filed 10–7–24; 8:45 am]
[FR Doc. 2024–23220 Filed 10–7–24; 8:45 am]
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Support for Research
Excellence (SuRE) Award and SuRE-First
Independent Research (SuRE-First) Award
(R16 Clinical Trial Not Allowed).
Date: November 7, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F36,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Noton K. Dutta, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F36, Rockville, MD
20892, 240–669–2857, noton.dutta@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 2, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–23175 Filed 10–7–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
17:23 Oct 07, 2024
Jkt 265001
PO 00000
Frm 00118
Fmt 4703
Sfmt 4703
E:\FR\FM\08OCN1.SGM
08OCN1
]]>Agencies
[Federal Register Volume 89, Number 195 (Tuesday, October 8, 2024)]
[Notices]
[Pages 81533-81534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23122]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Mechanisms of Diabetic Cardiovascular
Disease.
Date: November 4, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manoj Kumar Valiyaveettil, Ph.D., Scientific
Review Officer, Office of Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208-R, Bethesda, MD 20817, (301) 402-1616,
email: [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Catalyze Product Definition for Small
Molecules and Biologics.
Date: November 6, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rajiv Kumar, Ph.D., Branch Chief, Blood and
Vascular Branch, Office of Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208-W, Bethesda, MD 20892, 301-827-4612,
email: [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Support for Conferences and Scientific
Meetings (R13).
Date: November 7, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Cynthia D. Anderson, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes Health, 6705 Rockledge Drive,
Room 207-E, Bethesda, MD 20892, email: [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Scientific Opportunities For Exploratory
Research.
Date: November 8, 2024.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sun Saret, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
208-S, Bethesda, MD 20892, (301) 435-0270, email: [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Review for Research Education Program to
Enhance Diversity in Health Related Research.
Date: November 8, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shelley Sehnert, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Suite 208-T, Bethesda, MD 20817, (301) 827-7984, email:
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Clinical Trials SEP (UG3, U24).
Date: November 12, 2024.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085, email:
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Mentored Career Development K-Awards.
Date: November 14, 2024.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085, email:
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Small Grant Program For NHLBI Award
Recipients (R03).
Date: November 20, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific
Review Officer, Office of Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208-Z, Bethesda, MD 20892, (301) 827-7987,
email: [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
[[Page 81534]]
Dated: October 2, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-23122 Filed 10-7-24; 8:45 am]
BILLING CODE 4140-01-P
